PMID: 2490818May 1, 1989Paper

Choosing initial therapy for hypertension. A personal view

Hypertension
H R Black

Abstract

With numerous safe and effective antihypertensive drugs now available, the clinician should no longer choose only diuretic agents or beta-adrenergic receptor blockers (beta-blockers) as initial therapy. Five classes of agents, including angiotensin converting enzyme inhibitors, beta-blockers, calcium entry blockers, peripheral alpha 1-adrenergic receptor blockers, and thiazide diuretic agents, are all appropriate monotherapy in properly selected patients. The choice depends on efficacy, side effects, demography, comorbidity, dosage schedule, cost, mechanism of drug action, and the pathophysiology of the patient's hypertension. Extensive data are now available that will assist the clinician in choosing an agent that has the greatest probability of success without the need for extensive biochemical or hemodynamic evaluation.

References

Aug 1, 1985·Journal of Hypertension·P WeidmannA Gerber
Dec 26, 1985·The New England Journal of Medicine·Y TagumaY Sasaki
Sep 1, 1983·Hypertension·J I Drayer, M A Weber
Nov 5, 1984·The American Journal of Medicine·J W Hollifield
Jan 1, 1982·British Journal of Clinical Pharmacology·K SilberbauerH Templ
Apr 1, 1981·The American Journal of Medicine·O B HollandL Kuhnert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.